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ABSTRACT: Alzheimer’s disease (AD) represents one major health concern for our growing elderly 
population. It accounts for increasing impairment of cognitive capacity followed by loss of executive function 
in late stage. AD pathogenesis is multifaceted and difficult to pinpoint, and understanding AD etiology will be 
critical to effectively diagnose and treat the disease. An interesting hypothesis concerning AD development 
postulates a cause-effect relationship between accumulation of mitochondrial DNA (mtDNA) mutations and 
neurodegenerative changes associated with this pathology. Here we propose a computerized method for an 
easy and fast mtDNA mutations-based characterization of AD. The method has been built taking into account 
the complexity of living being and fractal properties of many anatomic and physiologic structures, including 
mtDNA. Dealing with mtDNA mutations as gaps in the nucleotide sequence, fractal lacunarity appears a 
suitable tool to differentiate between aging and AD. Therefore, Chaos Game Representation method has been 
used to display DNA fractal properties after adapting the algorithm to visualize also heteroplasmic mutations. 
Parameter β from our fractal lacunarity method, based on hyperbola model function, has been measured to 
quantitatively characterize AD on the basis of mtDNA mutations. Results from this pilot study to develop the 
method show that fractal lacunarity parameter β of mtDNA is statistically different in AD patients when 
compared to age-matched controls. Fractal lacunarity analysis represents a useful tool to analyze mtDNA 
mutations. Lacunarity parameter β is able to characterize individual mutation profile of mitochondrial 
genome and appears a promising index to discriminate between AD and aging. 
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The introduction in gerontologic field of paradigms, such 
as theory of complexity, chaos, and fractals, provide new 
tools and suggest new approaches to the study of aging 
processes. Apparent contradictions, or phenomena 
apparently unexplainable, become understandable in the 
light of these new paradigms. As an example, the 
variability observed in senescent phenotype can be 
explained in the light of the theory of complexity by 
considering longevity as a “secondary product” of 
evolution of a dynamic nonlinear system [1,2]. 
Complex systems are highly dependent upon initial 
conditions; thus, in a cohort, even very small differences 
occurring at certain times can cause higher and higher 
differences at later ages in most characteristics of 
   Volume 8, Number 1; 44-56, February 2017                       
 Zaia A., et al                                                                                                    Lacunarity of mtDNA in Alzeimer’s Disease   
Aging and Disease • Volume 8, Number 1, February 2017                                                                               45 
 
individual phenotype. In this view, by considering living 
systems as complex systems [3], life trajectories of 
subjects in a population, whatever close at birth, will 
evolve fluctuating with time, progressively enlarging the 
variance of their phenotype characteristics, among which 
aging. Even in the presence of genetically homogeneous 
backgrounds, inter-individual variability is always present 
independently of how large environmental changes are. 
In fact, genetic-environment interaction causes 
unpredictable behavior at bifurcations (critical points at 
which changes of trajectory can occur). Bifurcations 
represent a source of variability responsible of 
heterogeneity of aging phenotype. 
The concept that a complex system with a chaotic 
behavior often generates fractal structures, the so-called 
strange attractors [4], that can be observed at critical 
points, highlights the usefulness of fractal analysis as a 
suitable tool to measure biocomplexity and its changes 
with aging at both functional and structural levels [5-8]. 
Fractal analysis can measure variations of complexity in 
biosystems evolving with time by following different 
trajectories. Individual specific genetic-environment 
interactions define the senescent phenotype as normal 
aging, pathologic aging, or successful aging [2]. Fractal 
analysis, therefore, represents a promising tool to give 
insight into the search of good biomarkers useful to 
discriminate between physiologic and pathologic aging as 
well as between age-related and age-associated diseases, 
two main tasks dealing with aging well. 
Alzheimer’s disease (AD) represents one major 
health concern for our growing elderly population. It 
accounts for increasing impairment of cognitive capacity 
followed by loss of executive function in late stage [9,10]. 
The expected increase in AD incidence [11] claims for a 
better understanding of the underlying etiology to achieve 
early diagnosis and effective treatments. However, AD 
pathogenesis is multifaceted and difficult to recognize.  
While a number of hypotheses have been proposed, the 
exact cause of AD is unknown. The most widely accepted 
hypothesis is the amyloid cascade hypothesis [12]: it 
posits amyloid-β (Aβ) plays an early and vital role in AD, 
as it triggers a cascade of events responsible for synaptic 
dysfunction, tau pathology, and neural loss [13].  
An interesting hypothesis concerning AD 
development postulates a cause-effect relationship 
between accumulation of mitochondrial DNA (mtDNA) 
mutations and neurodegenerative changes associated with 
this pathology such as defective oxidative 
phosphorylation, increased oxidative stress, accumulation 
of Aβ, and apoptosis [14,15]. Human cells contain 
thousands of mtDNA copies and the most common 
mutations are insertions, deletions, and point mutations 
that are classified as homoplasmic or heteroplasmic if 
they regard all mtDNA copies or only a fraction of them, 
respectively [16,17].  
When we approach studies on DNA sequences as it is 
searching for mutations in mtDNA, we have to face the 
problem of handling a huge data set by quite time 
consuming procedures. In addition, the wide variety of 
DNA mutations, in this particular context the mtDNA 
ones, found in both AD patients and control subjects 
makes the genetic characterization of AD very demanding 
during all kinds of analytical procedures used, both 
numerical and statistical. 
Here we propose a computerized method for an easy 
and fast mtDNA mutations-based characterization of AD. 
The method has been built taking into account the 
complexity of living being and fractal properties of many 
anatomic and physiologic structures [18-21], among 
which is mtDNA [22]. The advent of fractal mathematics 
to describe complex structures in biology and medicine 
has been accepted by most scientists and an always 
increasing number of fractal analysis techniques have 
been proposed and applied. However, the application of 
fractal techniques is often limited to fractal dimension 
(DF). As a matter of fact, DF has been proposed and used 
as a suitable tool to measure complexity variation of most 
biomedical functions and structures during aging and 
disease [23-29]. This has been happening also in the case 
of DNA structure [30-34]. While DF gives an estimate of 
the complexity of the structure, it alone is not sufficient to 
characterize a fractal object. Lacunarity instead, another 
fractal property, describes the texture of a fractal and can 
measure fractal space filling capacity [35]. The term 
lacunarity, from Latin lacuna, lack or hole, was coined by 
Mandelbrot referring to gap distribution in a fractal 
[20,35], and lacunarity analysis was initially introduced to 
differentiate fractal objects displaying the same DF but 
having a very different appearance. A third fractal 
property, namely succolarity, introduced by Mandelbrot 
[36] has been recently reconsidered for analytical 
applications to further characterize fractal objects 
accounting for the connectivity of their structure 
[34,37,38].  
Taking into account the limits of fractal analysis 
applied to natural objects [2,35,39], fractal lacunarity 
analysis has been used to develop our method. In fact, 
self-similarity and invariance of scale are properties 
belonging to ideal fractals: they show exact or 
approximate self-similarity. When fractal properties are 
considered in biology and medicine we deal with 
statistical self-similarity in a limited range of scale. 
Furthermore, multifractal structures are common. More 
recently, lacunarity analysis has been introduced as a 
more general technique able to describe random and 
fractal spatial patterns. Thus, lacunarity analysis can be 
used to describe the texture of complex objects with 
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fractal, multifractal or non-fractal properties [39,40]. In 
addition, dealing with mtDNA mutations as gaps in the 
nucleotidic sequence, fractal lacunarity appears a suitable 
tool to differentiate between aging and AD. Therefore, in 
the present paper we provide a preliminary study where 
fractal lacunarity is candidate as a potential pathologic 
index regarding mutated mtDNA structure.  
Chaos Game Representation method has been used to 
display DNA fractal properties [41-44] after adapting the 
original algorithm to visualize heteroplasmic mutations 
peculiar to mtDNA. Parameter β, from our fractal 
lacunarity method based on hyperbola model function 
[45-48], is the measure used to quantitatively characterize 
AD on the basis of mtDNA mutations. 
 
MATERIALS AND METHODS 
 
Subjects 
 
This study was performed on 28 subjects, 14 AD patients 
and 14 age-matched controls, enrolled from October 2009 
to September 2010 at the INRCA Geriatrics Unit of Fermo 
after approval by the Institutional Ethical Committee. 
Each subject included in the study, or caregiver when 
necessary, provided informed consent to participate. 
Patients were diagnosed according to National Institute of 
Neurological and Communicative Diseases and 
Stroke/Alzheimer’s Disease and Related Disorders 
Association (NINCDS-ADRDA) criteria for probable AD 
by an extended neuropsychological and functional 
evaluation, neuroimaging, and laboratory tests. Controls 
were volunteers and relatives of the patients and 
underwent the same diagnostic assessment as the AD 
group (Table 1). 
 
Table 1. Characteristics of subjects included in the study 
 
 
 AD patients Controls p Value 
Number (M/F) 2/12 1/13  
Age 75.4 ± 5.1 73.1 ± 5.1 0.117 
MMSE 17.3 ± 3.4 28.2 ± 0.8 <0.001 
ADL 5.2 ± 1.3 6.0 ± 0.0 0.022 
IADL 2.0 ± 1.4 8.0 ± 0.0 <0.001 
Values are expressed as mean ± SD;  
p Values have been calculated by one-tail t-test;  
AD: Alzheimer’s Disease; MMSE: Mini Mental State Examination; ADL: 
Activities of Daily Living; IADL: Instrumental Activities of Daily Living 
 
MitoChip v2.0 resequencing array protocol and array 
analysis 
 
Mitochondrial DNA sequences were from a previous 
study [49] in which DNA was processed and analyzed as 
follows. Total DNA from whole blood of AD patients and 
age-matched controls was extracted by QIAamp DNA 
Blood Mini kit (Qiagen, Hilden, Germany) and amplified 
by REPLI-g mitochondrial DNA kit (Qiagen, Hilden, 
Germany). Purified DNA was fragmented and labeled by 
Genechip Resequencing array kit (Affymetrix, Santa 
Clara, CA). MitoChip arrays were loaded with DNA, then 
washed and stained (Fluidics Station 450) before being 
scanned in Affymetrix GeneChip Scanner 3000 7G. 
Affymetrix MitoChip v2.0, allowing mtDNA 
sequences analysis with high reproducibility and 
sensitivity [50,51], is a mtDNA sequencing array with 
eight 25-mer probes/base position (four oligonucleotide 
probes/strand) corresponding to the whole revised 
Cambridge Reference Sequence (rCRS). Each 25-mer 
probe is varied at the central position to incorporate each 
possible nucleotide (A, G, C, or T). Data set were acquired 
by the Affymetrix Genechip Command Console (AGCC) 
software and analyzed with GSEQ 4.1. This software 
elaborates fluorescence intensity data by means of an 
algorithm whose parameters were defined to achieve 
optimal performance in analyzing mitochondrial 
sequences, with “model type” set at diploid to enable the 
detection of heteroplasmy and “quality score threshold” 
set at 3 to provide the best base calling accuracy and rate. 
We included in the analysis chips whose call rate was 
>95% implying that unclassified nucleotide positions 
(nps), known as no-calls, had to represent a very small 
percentage of total calls.  
The output files used for our analysis were the Single 
Nucleotide Polymorphism (SNP) View files that provide, 
for each np, the corresponding base call. If the call is 
different from the corresponding rCRS base, we are in the 
presence of a mutation which is classified by the software 
as homoplasmic or heteroplasmic. Data discussed here 
were deposited in NCBI’s Gene Expression Omnibus [52] 
and are accessible through GEO Series accession number 
GSE49160 (www.ncbi.nlm.nih.gov/geo/query/acc.cgi? 
acc =GSE49160). 
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Figure 1.  Chaos Game Representation method. CGR organization for L=1,2,3 in the case of mtDNA four-symbol alphabet 
sequence. 
 
Chaos Game Representation of mtDNA 
 
Data set of mtDNA from Affymetrix system were 
transferred into a personal computer to be processed and 
analyzed as follows. The Chaos Game Representation 
(CGR) method was used to analyze the structure of 
mtDNA, see Jeffrey [41] for the pioneering work on this 
subject. This is a method that produces images from long 
sequences; therefore, it can be also applied to DNA 
information. An important problem in CGR theory is the 
connection of the genetic properties of DNA sequence and 
the fractal features of the corresponding CGR images. 
Let S be a DNA sequence; it can be seen as a finite string 
with respect to the alphabet {a, c, g, t}. The CGR image 
of S describes the frequency occurrence of all the possible 
substrings with fixed length L. Due to the four-symbol 
alphabet of S, this map can be organized in a square matrix 
of order 2L.  Figure 1 shows a pictorial description of this 
organization for L=1,2,3. 
A precise definition of this organization can be given 
by matrix tensor product; in fact, defining M1 as the 2x2 
matrix in the case L=1, matrix ML in the generic case L is 
defined as follows: 
 
 .
  timesL
    MMMM L   
 
From this definition, for every integer L, a well-
defined position p(s) is associated to each possible 
substring sϵS of length L. 
Thus, given a positive integer L, the CGR matrix A of a 
given DNA sequence S can be constructed by using a 
simple algorithm:  
1. initialize A to a zero matrix having 2L rows and 
2L columns,  
2. for each substring sϵS increase by one the entry 
of A having position p(s).  
An efficient implementation of this algorithm in a 
computer code is not a trivial task, see Vinga et al. [53] 
for details. 
We propose a slight modification of the original 
algorithm in order to deal with undetermined DNA typing 
symbols (heteroplasmic mutations). In particular, 
substrings s having undetermined symbols are considered 
as the multiple strings generated by solving these 
undetermined symbols; each one of such strings having a 
fractional weight depending on the number of generated 
strings. 
For the sake of clarity an example (L=5) is reported. 
String s=’tamcg’, where ‘m’ means ‘a’ or ‘c’, is expanded 
in s1=’taacg’ and s2=’taccg’ having weigth 1/2. String 
s=’tavcg’, where ‘v’ means ‘a’, ‘c’, or ‘g’ is expanded in 
s1=’taacg’, s2=’taccg’, s3=’tagcg’ having weight 1/3.  
In this way, the above mentioned algorithm can be 
easily adapted to work also with substrings containing 
undetermined symbols; in this case, substrings containing 
a heteroplasmic mutation are expanded in multiple strings 
that are processed by the above algorithm with the 
exception that the string weight is used for the increment 
of CGR matrix entry. 
The algorithm above described for CGR was 
implemented in software such that, while generating a 
matrix, it also provides a report with additional 
information on mtDNA sequence processed, i.e. type and 
number of nucleotide(s), number and position of 
homoplasmic/heteroplasmic mutations. 
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Estimate of lacunarity 
  
Fractal lacunarity analysis of mtDNA images as generated 
by CGR was performed by adopting a method previously 
developed in our laboratory as described in [45,46] and 
modified in [47,48]. 
In particular, among the definitions and calculating 
procedures proposed to estimate lacunarity, we chose the 
gliding box algorithm, GBA, based on the analysis of 
mass distribution in the set [40]. This method involves the 
variance of the box mass, M, at each step, wherein the box 
is moved one space unit at a time. The box mass is 
recounted till the whole region is traversed thus producing 
a frequency distribution of box masses, n(M,b), where b 
is the size of the gliding box.  
For the sake of simplicity we assume that, for each b, 
only a finite number of masses Mj, j=1,2,…,μ(b) are 
encountered in the various gliding boxes of size b; 
therefore, a discrete frequency distribution n(Mj,b), 
j=1,2,…, μ(b) has to be considered. Note that such an 
assumption holds for binary images, where the mass of a 
generic box on the image is given by the number of white 
pixels in the box, i.e. the pixels associated to the value 
one. From standard arguments on probability the 
moments of order q of M, are given by: 
 
 
  
 
 
where the division by N(b), i.e. the total number of boxes, 
needs to convert n(Mj,b), j=1,2,…,μ(b) into a probability 
distribution. The definition of lacunarity function Λ uses 
only the first and the second moments of M, that is 
 
 
 
 
 
A simple extension of this algorithm can be used to deal 
with gray scale images. In this extension the moment 
formula for the discrete distribution of M is upgraded with 
the moment formula for M taking a continuous range of 
possible values, see Zaia et al. [47] for details. The 
efficiency of such an extension is usually improved by a 
different pre-processing step through a sigmoid function. 
In particular, this new pre-processing step prescribes to 
consider image J, in place of image I, where the pixels are 
defined as follows: 
 
 
 
,,...,2,1,,...,2,1,
))),((exp(1
1
),( NcoljNrowsi
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

 
 
and k, σ > 0 are two given parameters. It is worth noting 
that the procedure goes toward a complete binarization by 
increasing parameter k, related to sigmoid regularization. 
The GBA method was implemented in software using 
MATLAB software package (the MatWorks, Inc.). The 
program begins to elaborate a gray-scale image coming 
from the above mentioned manipulation of mtDNA 
images. 
It calculates the values of lacunarity, for each integer 
value of b between bmin and bmax, where bmin, bmax are given 
integer multiples of the pixel size in the image under 
consideration. Once the lacunarity function Λ(b), b=bmin, 
bmin+1,…, bmax is obtained, the program shows the results 
on a graph.   
As expected from the asymptotic properties of 
function Λ on fractal set [40], for all the images analyzed, 
the behaviour of lacunarity function was a curvilinear plot 
resembling the hyperbola one; therefore, the following 
model: 
 
 ],[,)( maxmin bbb
b
bL  


 
 
was chosen to approximate the lacunarity function [45]; 
note that α, β, γ are suitable parameters.  
This observation is consistent with the theoretical 
behaviour of lacunarity function Λ for self-similar fractals 
and for other different random sets. Moreover, for such 
fractals, parameter α is related to DF of the set and 
parameter β characterizes the lacunarity of the set [45,46]. 
In each particular example considered in this study, the 
best interpretation of lacunarity Λ(b), b=bmin, bmin+1,…, 
bmax, by the model function L(b), b [bmin, bmax], was 
computed as the solution of a least squares problem, 
where parameters α, β, γ are the independent variables. In 
particular, the minimizer of this problem is a triplet of 
parameters (α*, β*, γ*) of the model function that better 
represents the variation of mass density of pixels in that 
image. 
 
Statistical analysis  
 
All data with normal distribution were presented as means 
± SD. Student's t-test was used to compare differences 
between AD and control groups. Statistical significance 
was accepted for p ≤ 0.05. 
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b
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Figure 2.  Chaos Game Representation of human mtDNA. 
Whole revised Cambridge Reference Sequence processed by 
CGR method generates matrices 2Lx2L. Matrices for L=1 to L=6 
are reported (a). CGR representation of human mtDNA 
resembles self-similarity of the triangle of Sierpinski, an ideal 
fractal built through repeated iterations starting from a square 
(b). 
 
RESULTS 
 
Our method of fractal lacunarity analysis based on 
hyperbola model function was systematically applied to 
CGR images generated by rCRS, mtDNA sequences from 
5 AD patients, and mtDNA sequences from 5 age-
matched controls to set up the method and test its 
robustness. In particular, for any set of matrices 2Lx2L 
(with L=1,2,….8) generated with CGR method, we 
obtained an identical set of reports for each mtDNA 
sequence processed for six times (data not shown). We 
also observed that for frame length L>8 a clear pictorial 
representation of the whole mtDNA fractal structure 
decreased because an increasing number of positions in 
the matrix are empty as the related substrings are rare or 
absent. This is consistent with the limited range of scale 
in which fractal properties can be observed in biological 
objects [2,35,39]. 
Twenty-eight mtDNA sequences from 14 AD 
patients and 14 controls were processed and analyzed to 
verify the potential of our lacunarity parameter β in 
characterizing alterations of mtDNA in aging and 
Alzheimer’s disease.  
 
 
 
Table 2. Characteristics of mtDNA sequences processed by the proposed method 
 
Number rCRS AD patients Controls p Value 
Subjects  14 14  
Adenosine 5117 5178.8 ± 9.4 5174.9 ± 7.4 0.115 
Cytosine 5175 4937.3 ± 28.9 4948.6 ± 11.9 0.095 
Guanine 2163 2266.1 ± 15.0 2264.3 ± 13.6 0.371 
Thymine 4089 4161.9 ± 12.4 4156.3 ± 15.0 0.076 
Total mutations  18 ± 10 23 ± 12 0.094 
Homoplasmic  14 ± 8 18 ± 9 0.090 
Heteroplasmic  3 ± 3 5 ± 4 0.119 
 
Values are expressed as mean ± SD;  
p Values have been calculated by one-tail t-test to compare differences between AD and Controls groups; 
rCRS: revised Cambridge Reference Sequence; AD: Alzheimer’s Disease 
 
 
 
Chaos Game Representation of human mtDNA 
 
Figure 2 shows a set of six CGR images generated from 
rCRS with matrices for L=1 to L=6. Note that fractal 
structure of human mtDNA starts to be evident for L=3. It 
resembles the Sierpinski triangle (Figure 2b). This 
observation is consistent with Wang et al. [54] that 
reported the same Sierpinski-like structure for human 
mtDNA, different from human nuclear DNA and from 
DNA of other species thus highlighting a species- and 
type-specificity of DNA fractal representation. 
Table 2 summarizes results on mtDNA sequences 
from the whole sample of 28 subjects. Fractional numbers 
for nucleosides are due to the presence of heteroplasmic 
mutations as computed by the proposed modified CGR 
algorithm. In particular, both AD and Control mtDNA 
sequences are altered when compared to rCRS. A similar 
set of mutations can be observed in AD and Control 
subjects with no statistical significant differences.  
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Figure 3.  Schematic representation of fractal lacunarity analysis. (Top left) rCRS 
mtDNA image generated by CGR matrix for L=5 is a 32x32 square. The plot (bottom) 
represents the result of GBA application (dotted line), for bmin=3, as fitted by hyperbola 
function (solid line) used to calculate the triplet of parameters , , γ. rCRS: revised 
Cambridge Reference Sequence; Chaos Game Representation; GBA: Gliding Box 
Algorithm. 
 
Fractal analysis of mtDNA in aging and Alzheimer’s 
disease 
 
Our method of fractal lacunarity analysis was 
systematically applied to CGR images generated from the 
above described mtDNA sequences for L=4 to L=7 to find 
the proper combination of coefficients for the best 
characterization of any mtDNA sequence analyzed. Both 
bmin and sigmoid coefficients (k and ) were considered: 
we found that for k equal to 7 and   equal to 0.7 we 
obtained comparable results for both bmin equal to 3 and 5 
when applied to matrices 2Lx2L for L equal to 5 and 6.  
Figure 3 shows a schematic representation of the 
method applied to a CGR matrix generated by rCRS. CGR 
matrices generated from all the mtDNA sequences 
produced a similar curvilinear plot. The almost perfect 
overlap of the two experimental and theoretic curves 
supports the appropriateness of our choice of hyperbola 
model function to fit the gliding box curve.  
Examples of mtDNA CGR images for L=5 and L=6 
from rCRS, AD patient, and age-matched control are 
reported in Fig. 4. In spite of a similar display among the 
three kind of mtDNA sequences, parameter  values 
significantly differ for both frame lengths considered. In 
particular, lower  values, observed in AD and Control 
mtDNA when compared to rCRS, correspond to a higher 
degree of mutations of the nucleotide sequences 
considered. 
Results in Table 3 were obtained from the application 
of our lacunarity method by using bmin equal to 3 pixels to 
CGR images from matrices with L equal to 5 generated 
from mtDNA sequences of 14 AD patients and 14 
Controls.  
It is worth noting that fractal lacunarity parameter β, 
representative of mutation-related changes of the 
sequence, is significantly lower in both AD and Controls 
subjects when compared to rCRS. In addition, a 
statistically significant difference exits between AD and 
Control mtDNA with a higher degree of mutated frames 
in Controls (lower β values).  
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Figure 4.  Examples of CGR images of mtDNA sequences 
from different subjects. Matrices for L=5 (top) and L=6 
(bottom) generated from mtDNA of rCRS (left), AD patient 
(middle), and Control (Ctr, right). Lacunarity parameter  value 
for each representation is reported. CGR: Chaos Game 
Representation; rCRS: revised Cambridge Reference Sequence; 
AD: Alzheimer’s Disease. 
 
 
 
Correlation of parameter β with classic diagnostic 
indices of Alzheimer’s disease 
 
In spite of the small sample under study, in the attempt to 
assign a diagnostic power to our lacunarity parameter β, a 
comparison with classic diagnostic indices was performed 
(Fig. 5). A cut-off value of parameter β equal to 1.68 
(median value from the whole sample) identifies 71% of 
AD patients (10 out of 14, true positive) and 29% of 
Controls (4 out of 14, false positive) against a 100% of 
AD by MMSE, 93% by IADL tests, and 29% by ADL test. 
Cognitive and neuropsychological assessment, based on 
MMSE, ADL, and IADL tests, represents the first choice 
in clinical practice to diagnose AD. Other diagnostic 
approaches, described in Table 4, follow to complete the 
clinical setting in doubt cases.  
 
DISCUSSION 
 
One most relevant aspect of aging populations is 
represented by the high degree of inter-individual 
variability. Ever increasing number of people is given to 
live longer; however, only a little percentage ages well. 
More than 60% of elderly people experience a pathologic 
aging, often characterized by co-morbidity. Heterogeneity 
of senescent phenotype has been, for long time, 
considered as an obstacle to understand and recognize 
“physiologic” aging, therefore making hard 
discriminating pathologic aging subjects. This is what is 
happening also in the case of Alzheimer’s disease. 
 
 
 
 
 
 
Figure 5.  Correlation of lacunarity parameter β with classical diagnostic indices of Alzheimer’s disease (AD). MMSE-Mini 
Mental State Examination (left); ADL-Activities of Daily Living (middle); IADL-Instrumental Activities of Daily Living (right). 
Triangles and circles represent AD patients and age-matched controls respectively. 
 
Here we show that fractal analysis represents a 
powerful tool to discriminate between aging and age-
related pathologies. In particular, fractal lacunarity 
analysis of mtDNA, performed by the proposed method, 
is able to highlight a statistical significant difference of 
mtDNA mutations phenotype between AD patients and 
age-matched controls, thus overcoming the limits of 
classical numerical and statistical methods.  
From the literature, it is quite accepted that 
mitochondrial dysfunction and oxidative damage play an 
important role in the pathogenesis of AD [55-60]; 
however, the mechanisms involved have not been clearly 
 Zaia A., et al                                                                                                    Lacunarity of mtDNA in Alzeimer’s Disease   
Aging and Disease • Volume 8, Number 1, February 2017                                                                               52 
 
identified yet [61-64]. Several studies since 90s have 
failed to find consistent mutational abnormalities in AD 
mtDNA beyond those associated with aging, with most 
studies carried out in postmortem brain.  As a matter of 
fact, sporadic mutations have been found increased in 
mtDNA control regions in AD patients compared to 
controls [65]; however, a study on Japanese patients failed 
to find any causal role of mtDNA mutations in the 
etiology of the disease [66]. It has been also reported that 
pathologic inherited mtDNA mutations do not represent a 
major etiological factor in sporadic AD; however, it seems 
that at least a little percentage of AD patients carry 
pathologic mtDNA mutations and a little percentage of 
normal aged individuals carry mtDNA mutations that 
protect them from AD onset [67]. These changes have 
been found both in brain and peripheral tissues, thus 
suggesting that AD can be regarded as a systemic disease 
[68]. 
 
 
Table 4. Different approaches to AD diagnosis used in clinical practice 
 
MMSE: Mini-Mental State Examination; NPI: Neuropsychiatric Inventory; ADL: Activities Daily Living; IADL: Instrumental Activities of Daily 
Living; AD: Alzheimer Disease; CT: Computed Tomography; MRI: Magnetic Resonance Imaging; PET: Positron Emission Tomography; CSF: 
Cerebrospinal Fluid 
 
 
 Target Advantages Disadvantages 
Cognitive and 
neuropsychological 
assessment 
Provides a detailed picture 
of cognitive status. Thinking 
skills that are explored 
include memory, language, 
visual-spatial perception, 
attention, motor function, 
and executive function (e. g. 
MMSE, NPI, ADL, IADL) 
Identifies very early subtle 
cognitive changes and which 
areas of mental functioning are 
affected. It can help distinguish 
AD from other forms of 
dementia.  The cost is low and 
the tests are not invasive. 
An abnormal result can have 
many explanations other than 
AD. It can miss cognitive 
impairment in those who are 
highly educated.  It can be tiring 
and stressful for patients being 
tested. 
Brain imaging CT scans and MRI examine 
structural changes of the 
brain. PET scans can show 
metabolic changes and 
amyloid deposition. 
Allows finding possible other 
causes of dementia symptoms 
(brain trauma, tumor, or stroke). 
PET scans can help distinguish 
AD from frontotemporal 
dementia. 
Brain imaging may require the 
use of intravenous "tracing" 
agents, that can cause side 
effects. MRI scanners can induce 
claustrophobia and may not be 
compatible with pacemakers or 
other devices. The cost is notably 
high. 
Spinal tests   The amounts of three AD 
biomarkers, amyloid-β 42, 
total tau, phosphorylated 
tau, are determined in CSF 
through a lumbar spine 
puncture. 
 
CSF biomarkers can identify 
patients without clinical or 
preclinical signs of AD. A low 
level of amyloid-β 42 in patients 
with mild cognitive impairment 
seems to predict with 80-90 % 
accuracy who will not develop 
AD. 
It is an invasive test to be 
performed by an expert high 
qualified specialist. Risk exists 
for infection, ble eding, and pain 
.  
    
Point mutations do not necessarily lead to the 
development of disease(s). The mitochondrial genome 
shows a high degree of polymorphism because of 
mutations, and mitochondria within cells differ from each 
other depending on their mitochondrial genome profile 
(heteroplasmy). However, significant differences in 
biochemical phenotype and pathological impact do not 
occur until the number of mutated mtDNA molecules 
reaches a critical threshold level of bioenergetic 
impairment which depends on both the type of 
accumulated mutations and the specific ATP requirement 
of the tissue [69]. 
According to “mitochondrial cascade hypothesis” 
two main events are responsible of disease onset: the rate 
of mitochondrial decline determined by inherited and 
acquired mutations, and the point at which adequate 
compensation and adaptation to age-related changes are 
no longer available. The kinetics of these two events 
define the age at which patients begin to experience 
clinical signs of the disease [70]. Severity of the 
symptoms has been correlated with the degree of 
heteroplasmy and the size of possible deletions [71]. The 
degree and pattern of neurodegeneration within patients 
with mitochondrial disease can vary depending on the 
type of mutations and mutation load segregation at level 
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of brain regions as a whole as well as at level of single 
neurons [17]. 
In this context, it sounds appropriate to call in cause 
the theory of complexity and the laws of chaos to explain 
and characterize individual phenotypes evolving over 
time as ‘normal’ aging or pathologic aging [2]. As above 
introduced, the variability observed in senescent 
phenotype can be explained in the light of the theory of 
complexity by considering longevity as a “secondary 
product” of evolution of a dynamic nonlinear system. In 
fact, biological systems, human beings in particular, can 
be considered complex systems, made up of numerous 
sub-systems (nervous, cardiovascular, endocrine, … 
systems), interacting with each other. Each sub-system is 
further subdivided into interacting lower components 
(organs, tissues, …) and so on at lower levels of 
organization. In particular, the organization into hierarchy 
and the laws of chaos can be called in cause to explain 
their evolution, from development to senescence through 
the maintenance of “homeostatic” dynamic equilibrium of 
all their integrated functions as an adaptive response to 
continuous noxae from both endogenous and exogenous 
environments. 
In the light of this holistic point of view, aging has 
been defined as the temporal evolution of a complex 
system, characterized by a nonlinear dynamic behavior 
governed by the laws of chaos. The system evolves, under 
the influence of both endogenous and exogenous 
environments, with loss of complexity during aging 
[6,7,19].  
Human beings, as complex systems with a chaotic 
behavior, generate fractals: they can be observed at both 
structural and functional levels. Therefore, fractal analysis 
emerges as a suitable tool to measure biocomplexity and 
its changes with aging and pathology. Fractal analysis can 
measure variations of complexity in biosystems that, 
evolving with time, follow different trajectories. The 
senescent phenotype evolves as ‘normal’ aging, 
pathologic aging, or successful aging depending on the 
individual specific genetic-environment interactions 
[1,2].  
As mentioned in the introduction, dealing with 
mtDNA mutations as gaps in the nucleotidic sequence, 
fractal lacunarity represents a suitable tool to differentiate 
between aging and AD. Fractal lacunarity, in fact, 
provides a holistic estimate of changes in mtDNA 
sequences comprising of number, type, and dislocation of 
mutation(s), the combination of which probably 
contributes to AD onset and progression.  
Lacunarity analysis of genomic sequences has been 
recently proposed as a potential bio-sequence analysis 
method in both prokaryotes and eukaryotes [72]. Our 
original method, based on hyperbola model function to 
quantify fractal lacunarity, was previously successfully 
applied to trabecular bone images to discriminate between 
aging and osteoporosis [45,46]. Here we propose a 
modified version [47,48] reviewed and adapted to operate 
on CGR images of mtDNA sequences to characterize 
individual mutation profile of mitochondrial genome. It is 
worth noting that mtDNA accounts for both homoplasmic 
and heteroplasmic mutations, the last ones identified in 
GSEQ 4.1 software by symbols other than four-symbols 
alphabet commonly used to represent DNA sequences. As 
far as in our knowledge, the modification of the original 
CGR algorithm introduced in this study to deal with 
heteroplasmic mtDNA mutations (undetermined DNA 
typing symbols) represents a novelty in the field. 
Parameter β from our original bio-mathematical model, 
representative of lacunarity, is sensitive to mtDNA 
sequence changes and is able to discriminate between AD 
patients, with clinical signs of disease, and age-matched 
controls. Lacunarity β value cut-off at 1.68, median value 
from the whole sample, identifies most AD patients. It is 
worth noting that the gold standard for AD diagnosis is 
represented by histological identification of amyloid 
plaques that can be performed only at the autopsy. All AD 
diagnostic tools used in clinical practice have some 
drawbacks and none of them can recognize AD with 
100% accuracy and specificity. Therefore, the 
identification of new AD biomarkers would be very 
useful, though the physio-pathological mechanisms of 
AD onset remains unknown. Phenotyping mtDNA 
mutations in AD by the proposed method could provide a 
clear-cut support to the hypothesis on AD 
etiopathogenesis based on a cause-effect relationship 
between accumulation of mtDNA mutations and AD-
related neurodegenerative changes. Particularly intriguing 
is the presence of a little percentage of controls showing a 
mtDNA mutation profile similar to AD: they could 
represent the lecture key to identify mtDNA mutation(s) 
that protect aged individuals from AD onset as well as 
pathologic mtDNA mutation(s) that predispose to the 
disease. Geneticists could use the proposed method as an 
easy and fast genomic screening tool to recognize altered 
nucleotidic sequences and then focus on specific 
mutation(s) found in particular nucleotide frame(s) of 
interest for onset and progression of AD. It has to be 
stressed that the proposed method has potential for a wide 
application to any pathology with genetic implications.  
In conclusion, fractal lacunarity analysis represents a 
useful tool to analyze mtDNA mutations. Parameter β 
from our method is able to characterize individual 
mutation profile of mitochondrial genome and appears a 
promising index to discriminate between AD and aging. 
Results presented in this paper are from a pilot study 
to set up the method and need to be confirmed in larger 
samples of patients in which gender- or even race-related 
differences could be also investigated. Anyhow, these 
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results give an interesting perspective: the quantitative 
characterization of mutated mtDNA features by fractal 
analysis. In this direction, the present study deserves 
further developments by exploring the other fractal 
properties, DF and succolarity, as well as other texture 
measures such as statistical approaches, co-occurrence 
matrix descriptors, power spectrum analysis. Exploiting 
the synergy among fractal measures to improve both 
texture recognition [73] and complexity characterization 
of mtDNA could make the difference in discriminating 
AD patients and controls having the same lacunarity 
parameter β.   
Improvements of the method are in progress for a 
morewide application as a smart screening tool to 
recognize altered long biological sequences (genomic and 
proteomic). It could represent a promising approach to 
give insight into the search of biomarkers of aging and 
pathologies. 
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